SOMAÍ Pharmaceuticals is a leading EU-GMP European pharmaceutical and biotech company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceuticals portfolio.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets.

SOMAÍ recently announced partnerships with Grow Pharma for UK distribution of the most differentiated cannabinoid-containing product portfolio, with the first product line launching in May 2024: https://www.einpresswire.com/article/...

Find out more about SOMAÍ at https://somaipharma.eu/

Discussing a range of topics including:

• Michaels background setting up medical cannabis cultivation facilities in the US. • The SOMAÍ product pipeline
• Medical vs recreational cannabis - the CEO's perspective.
• Developments n German and USA cannabis legislation.
• The nuanced differences between different medical cannabis markets internationally (UK, Germany, Australia and North America).

...and much much more.

-----------------------------------------------------------------------------------------------------

Grow Conversations is your window into the world of medical cannabis.

Brought to you by Grow Pharma - Unlocking the Medical Potential of Cannabis

Grow Pharma's Links: https://linktr.ee/grow_pharma
Grow Group's Links: https://growgroup.komi.io/
Follow Alex: https://linktr.ee/alexfrasercan...